News and events
Find out the latest news and updates about the regulation of therapeutic goods in Australia, as well as events, webinars and consultations with the community.
This page is in Beta testing. We welcome your feedback and suggestions as we look to improve this page.
Industry notices and compliance undertakings
Notifications for sponsors, manufacturers, and advertisers about official decisions and new or updated regulatory requirements, as well as information about recent regulatory compliance and enforcement actions.
-
Regulatory decision notices
Access official regulatory decisions for sponsors, manufacturers and advertisers, including GMP clearances, listing notices, administrative instruments, and updates to regulatory requirements. -
Latest articles
-
Product Information safety updates - August 2026
Information for health professionals about medicines with safety related updates to their Product Information. -
TGA to consult on additional controls for an active sunscreen ingredient
We have conducted a review and are proposing options for additional safeguards for 4-methylbenzylidene camphor (4-MBC), an active ingredient used in some Australian sunscreens. -
Updated classification rules for certain combination products
Updated classification rules for non-invasive medical devices that are used to maintain the patency or flush the lumen of another medical device.
Latest publications
-
We conducted a safety review of 4-Methylbenzylidene camphor (4-MBC), an active ingredient in therapeutic sunscreens.
-
TGA Laboratories has released a report describing our assessment of the 2026 seasonal flu vaccine
-
Communique from the 13th meeting of the Women's Health Products Working Group, 16 July 2026.
Latest consultations
-
Have your say about the content and level of detection for ethylene oxide, propylene oxide and epichlorohydrin in end use products.
-
Have your say about proposals to amend the Poisons Standard in relation to 4-methylbenzylidene camphor (4-MBC). These will be considered at the next meeting of the joint meeting of Advisory Committee on Medicines Scheduling (ACMS) and Advisory Committee on Chemicals Scheduling (ACCS).
-
Have your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Chemicals Scheduling (ACCS).